Ryunosuke Kogo

2.9k total citations · 1 hit paper
38 papers, 2.1k citations indexed

About

Ryunosuke Kogo is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Ryunosuke Kogo has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Surgery and 12 papers in Otorhinolaryngology. Recurrent topics in Ryunosuke Kogo's work include Head and Neck Cancer Studies (10 papers), Ear and Head Tumors (9 papers) and Cancer-related molecular mechanisms research (6 papers). Ryunosuke Kogo is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Ear and Head Tumors (9 papers) and Cancer-related molecular mechanisms research (6 papers). Ryunosuke Kogo collaborates with scholars based in Japan, Canada and United States. Ryunosuke Kogo's co-authors include Koshi Mimori, Masaki Mori, Fumiaki Tanaka, Shizuo Komune, Tomoya Sudo, Kohei Shibata, Akira Suzuki, Kohichi Kawahara, Satoru Miyano and Seiya Imoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Ryunosuke Kogo

33 papers receiving 2.0k citations

Hit Papers

Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Ch... 2011 2026 2016 2021 2011 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryunosuke Kogo Japan 14 1.7k 1.6k 242 159 145 38 2.1k
Leyuan Zhou China 15 762 0.5× 843 0.5× 288 1.2× 89 0.6× 104 0.7× 37 1.3k
Ma-Yan Huang China 9 1.1k 0.7× 1.3k 0.8× 225 0.9× 65 0.4× 29 0.2× 9 1.6k
Qing‐Mei He China 21 648 0.4× 893 0.5× 287 1.2× 70 0.4× 48 0.3× 44 1.3k
Rong-Zhen Luo China 20 346 0.2× 737 0.5× 274 1.1× 216 1.4× 134 0.9× 40 1.2k
Nilva K. Cervigne Brazil 16 560 0.3× 730 0.4× 211 0.9× 76 0.5× 33 0.2× 26 1.1k
Yayi Hou China 12 1.3k 0.8× 1.3k 0.8× 227 0.9× 101 0.6× 95 0.7× 14 1.7k
Jiewei Chen China 17 603 0.4× 901 0.6× 275 1.1× 95 0.6× 46 0.3× 44 1.3k
Massimiliano Mellone United Kingdom 19 494 0.3× 693 0.4× 514 2.1× 83 0.5× 54 0.4× 24 1.2k
Keiichi Koshizuka Japan 24 920 0.6× 993 0.6× 129 0.5× 61 0.4× 19 0.1× 37 1.2k
Chang–Gong Liu United States 11 1.9k 1.2× 2.0k 1.2× 273 1.1× 149 0.9× 93 0.6× 13 2.5k

Countries citing papers authored by Ryunosuke Kogo

Since Specialization
Citations

This map shows the geographic impact of Ryunosuke Kogo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryunosuke Kogo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryunosuke Kogo more than expected).

Fields of papers citing papers by Ryunosuke Kogo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryunosuke Kogo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryunosuke Kogo. The network helps show where Ryunosuke Kogo may publish in the future.

Co-authorship network of co-authors of Ryunosuke Kogo

This figure shows the co-authorship network connecting the top 25 collaborators of Ryunosuke Kogo. A scholar is included among the top collaborators of Ryunosuke Kogo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryunosuke Kogo. Ryunosuke Kogo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Matsuo, Mioko, et al.. (2024). Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma. Cancer Diagnosis & Prognosis. 4(5). 658–666.
3.
Jiromaru, Rina, Ryuji Yasumatsu, Mioko Matsuo, et al.. (2024). Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience. Cancer Diagnosis & Prognosis. 4(2). 105–110. 4 indexed citations
4.
Komune, Noritaka, Kuniaki Sato, Mayumi Ono, et al.. (2023). Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2. Scientific Reports. 13(1). 19636–19636.
5.
Matsuo, Mioko, Kazuki Hashimoto, Ryunosuke Kogo, et al.. (2023). Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies. In Vivo. 37(5). 2147–2154. 1 indexed citations
6.
Matsuo, Mioko, Muneyuki Masuda, Moriyasu Yamauchi, et al.. (2023). Pembrolizumab MonotherapyVersusPembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma. In Vivo. 37(5). 2188–2196. 5 indexed citations
7.
Kogo, Ryunosuke, Takeshi Iwaya, Satoshi Nishizuka, et al.. (2022). Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma. Cancer Medicine. 11(21). 3960–3968. 27 indexed citations
8.
Matsuo, Mioko, Kazuki Hashimoto, Takuro Isoda, et al.. (2022). Utility of FDG PET at the Initial Radioiodine Therapy in Differentiated Thyroid Cancer. Anticancer Research. 43(1). 183–190. 3 indexed citations
9.
Nakano, Takafumi, Ryuji Yasumatsu, Ryunosuke Kogo, et al.. (2019). Parotid gland carcinoma: 32 years’ experience from a single institute. The Journal of Laryngology & Otology. 133(7). 604–609. 11 indexed citations
10.
Yasumatsu, Ryuji, Takafumi Nakano, Kazuki Hashimoto, et al.. (2018). The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma. Auris Nasus Larynx. 46(1). 135–140. 12 indexed citations
11.
Yasumatsu, Ryuji, Masanobu Sato, Ryutaro Uchi, et al.. (2017). The treatment and outcome analysis of primary squamous cell carcinoma of the thyroid. Auris Nasus Larynx. 45(3). 553–557. 14 indexed citations
12.
Nakashima, Torahiko, et al.. (2017). Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer. International Journal of Clinical Oncology. 22(3). 442–447. 6 indexed citations
13.
Ishibashi, Masahisa, Ryunosuke Kogo, Kohei Shibata, et al.. (2013). Clinical Significance of PICT1 in Patients of Hepatocellular Carcinoma with Wild-Type TP53. Annals of Surgical Oncology. 20(S3). 537–544. 9 indexed citations
14.
Uchi, Ryutaro, Ryunosuke Kogo, Kohichi Kawahara, et al.. (2013). PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression. British Journal of Cancer. 109(8). 2199–2206. 31 indexed citations
15.
Suzuki, Akira, Ryunosuke Kogo, Kohichi Kawahara, et al.. (2012). A new PICTure of nucleolar stress. Cancer Science. 103(4). 632–637. 49 indexed citations
16.
Iwaya, Takeshi, Takehiko Yokobori, Naohiro Nishida, et al.. (2012). Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis. 33(12). 2391–2397. 148 indexed citations
17.
Ishibashi, Masahisa, Ryunosuke Kogo, Kohei Shibata, et al.. (2012). Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncology Reports. 29(3). 946–950. 212 indexed citations
18.
Kogo, Ryunosuke, Koshi Mimori, Fumiaki Tanaka, Shizuo Komune, & Masaki Mori. (2011). Clinical Significance of miR-146a in Gastric Cancer Cases. Clinical Cancer Research. 17(13). 4277–4284. 179 indexed citations
19.
Kogo, Ryunosuke, Teppei Shimamura, Koshi Mimori, et al.. (2011). Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers. Cancer Research. 71(20). 6320–6326. 1070 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026